Caring Cross Announces Promising Clinical Data with Single-Dose anti-HIV CAR-T Cell Therapy

BOSTON, May 12, 2026 /PRNewswire/ -- Today, at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in Boston, Massachusetts, Caring Cross announced early clinical data from a first-in-human Phase I/IIa trial of a novel CAR-T cell strategy in people living with HIV. The...